Home › Edwards Lifesciences Bullish on TMVR But Scant on Details
 

Keywords :   


Edwards Lifesciences Bullish on TMVR But Scant on Details

2015-10-29 02:04:09| Biotech - Topix.net

Edwards Lifesciences is betting on a big opportunity in transcatheter mitral valve replacement, but offers up very few details on the status of its efforts in that area. Edwards Lifesciences continued to wow analysts with its transcatheter heart valve sales results on its earnings call on Monday, but to a certain extent the attention of analysts has shifted to what they hope will be the next thing pushing revenue higher: Transcatheter mitral valve replacement.

Tags: on details edwards scant

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.05Ofcom reviews future of DTT in the UK
17.05GTPL offers cable TV directly on Samsung TVs using TVKey
17.05China takes sweeping action to ease property crisis
17.05Warner Bros. Discovery adds 2 million DTC subscribers in 1Q 2024
17.05LOréal Patents Hybrid Mineral and Organic Sunscreen
17.05Telefónica pay TV accesses down 45,000 in 1Q 2024
17.05Eastern North Pacific Tropical Weather Outlook
17.05Atlantic Tropical Weather Outlook
More »